EBOOK: Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity and Quality
Title | EBOOK: Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity and Quality PDF eBook |
Author | Elias Mossialos |
Publisher | McGraw-Hill Education (UK) |
Pages | 390 |
Release | 2004-06-16 |
Genre | Medical |
ISBN | 0335226558 |
"This thoughtful and comprehensive book represents the best work I have seen on the current situation concerning medication policies in the EU. It is not just that this is a very up-to-date compendium of facts and data across a wide variety of domains that impact on pharmaceutical regulation. The book is also strong on analysis of those facts as well." Jerry Avorn, Harvard Medical School. "This book offers a comprehensive examination of approaches to manage pharmaceutical expenditures in Europe. It is a must-read for those who seek to understand and navigate the changing regulatory environment for medicines in the European Union." Bernie O'Brien, McMaster University, Canada. The rising cost of pharmaceutical expenditures in many European countries is of concern to governments required to make effective use of health care budgets. Taking a broad perspective that encompasses institutional, political and supranational aspects of pharmaceutical regulation, this book examines approaches used to manage pharmaceutical expenditure across Europe and what impact these strategies have had on efficiency, quality, equity and cost of pharmaceutical care.Regulating Pharmaceuticals in Europe is an important book for students of health policy, regulation and management, and for health managers and policy makers. The editors: Elias Mossialos is Brian Abel-Smith Professor of Health Policy at the London School of Economics and Political Science and a Research Director of the European Observatory on Health Systems and Policies. Monique Mrazek is a Health Economist (Europe and Central Asia region) for the World Bank and formerly a Research Officer in Health Economics for the European Observatory on Health Systems and Policies. Tom Walley is Professor of Clinical Pharmacology at the University of Liverpool and Director of the UK National Health Technology Assessment Programme. Contributors: Julia Abelson, Christa Altenstetter, Vittorio Bertele’, Christine Bond, Marcel L. Bouvy, Colin Bradley, Steve Chapman, Anna Dixon, Michael Drummond, Pierre Durieux, Edzard Ernst, Armin Fidler, Eric Fortess, Richard Frank, Silvio Garattini, Leigh Hancher, Ebba Holme Hansen, Steve Hudson, Kees de Jonchere, Panos Kanavos, Sjoerd Kooiker, Jean-Marc Leder, Graham Lewis, Donald W. Light, Alistair McGuire, Elias Mossialos, Monique Mrazek, Maria Pia Orru', Govin Permanand, Guenka Petrova, Munir Pirmohamed, Dennis Ross-Degnan, Frans Rutten, Steven Soummerai, David Taylor, Sarah Thomson, Tom Walley.
REGULATING PHARMACEUTICALS IN EUROPE: STRIVING FOR EFFICIENCY, EQUITY, AND QUALITY; ED. BY ELIAS MOSSIALOS.
Title | REGULATING PHARMACEUTICALS IN EUROPE: STRIVING FOR EFFICIENCY, EQUITY, AND QUALITY; ED. BY ELIAS MOSSIALOS. PDF eBook |
Author | |
Publisher | |
Pages | 0 |
Release | 2004 |
Genre | |
ISBN |
Regulating Pharmaceuticals In Europe: Striving For Efficiency, Equity And Quality
Title | Regulating Pharmaceuticals In Europe: Striving For Efficiency, Equity And Quality PDF eBook |
Author | Mossialos, Elias |
Publisher | McGraw-Hill Education (UK) |
Pages | 390 |
Release | 2004-06-01 |
Genre | Education |
ISBN | 0335214657 |
"This thoughtful and comprehensive book represents the best work I have seen on the current situation concerning medication policies in the EU. It is not just that this is a very up-to-date compendium of facts and data across a wide variety of domains that impact on pharmaceutical regulation. The book is also strong on analysis of those facts as well." Jerry Avorn, Harvard Medical School. "This book offers a comprehensive examination of approaches to manage pharmaceutical expenditures in Europe. It is a must-read for those who seek to understand and navigate the changing regulatory environment for medicines in the European Union." Bernie O'Brien, McMaster University, Canada. The rising cost of pharmaceutical expenditures in many European countries is of concern to governments required to make effective use of health care budgets. Taking a broad perspective that encompasses institutional, political and supranational aspects of pharmaceutical regulation, this book examines approaches used to manage pharmaceutical expenditure across Europe and what impact these strategies have had on efficiency, quality, equity and cost of pharmaceutical care.Regulating Pharmaceuticals in Europe is an important book for students of health policy, regulation and management, and for health managers and policy makers. The editors: Elias Mossialos is Brian Abel-Smith Professor of Health Policy at the London School of Economics and Political Science and a Research Director of the European Observatory on Health Systems and Policies. Monique Mrazek is a Health Economist (Europe and Central Asia region) for the World Bank and formerly a Research Officer in Health Economics for the European Observatory on Health Systems and Policies. Tom Walley is Professor of Clinical Pharmacology at the University of Liverpool and Director of the UK National Health Technology Assessment Programme. Contributors:Julia Abelson, Christa Altenstetter, Vittorio Bertele’, Christine Bond, Marcel L. Bouvy, Colin Bradley, Steve Chapman, Anna Dixon, Michael Drummond, Pierre Durieux, Edzard Ernst, Armin Fidler, Eric Fortess, Richard Frank, Silvio Garattini, Leigh Hancher, Ebba Holme Hansen, Steve Hudson, Kees de Jonchere, Panos Kanavos, Sjoerd Kooiker, Jean-Marc Leder, Graham Lewis, Donald W. Light, Alistair McGuire, Elias Mossialos, Monique Mrazek, Maria Pia Orru', Govin Permanand, Guenka Petrova, Munir Pirmohamed, Dennis Ross-Degnan, Frans Rutten, Steven Soummerai, David Taylor, Sarah Thomson, Tom Walley.
Regulating Medicines in Europe
Title | Regulating Medicines in Europe PDF eBook |
Author | John Abraham |
Publisher | Psychology Press |
Pages | 260 |
Release | 2000 |
Genre | Drugs |
ISBN | 9780415208789 |
This book presents a critical appraisal of medicines regulation policy and exposes the influence of the pharmaceutical industry in the acceleration of drug approvals.
Implications of Future EU Policy on the Provision of Medicines and on Actors in the European Pharmaceutical Sector
Title | Implications of Future EU Policy on the Provision of Medicines and on Actors in the European Pharmaceutical Sector PDF eBook |
Author | Ewout Johan Marius van Ginneken |
Publisher | Univerlagtuberlin |
Pages | 210 |
Release | 2009 |
Genre | |
ISBN | 379832235X |
Health Policy and European Union Enlargement
Title | Health Policy and European Union Enlargement PDF eBook |
Author | Mckee |
Publisher | McGraw-Hill Education (UK) |
Pages | 312 |
Release | 2004-04-01 |
Genre | Medical |
ISBN | 0335226442 |
While there may be consensus on the broader issues of the core objectives of the health care system, expectations differ between EU countries, and European national policy-makers. This book seeks firstly to assess the impact of the enlargement process and then to analyse the challenges that lie ahead in the field of health and health policy.
The European Pharmaceutical Sector and Crime Vulnerabilities
Title | The European Pharmaceutical Sector and Crime Vulnerabilities PDF eBook |
Author | Tom Vander Beken |
Publisher | Maklu |
Pages | 220 |
Release | 2007 |
Genre | Organized crime |
ISBN | 9046601064 |
The influence of organised crime on business activities, enterprises and economic sectors is a matter of concern for many policy makers across the world. As a profit driven criminal activity, organised crime operates in an environment which is not limited to the underworld economy alone. Assessments of the threat posed by organised crime and strategic (preventive) actions to tackle this phenomenon require an understanding of the vulnerable spots in the legal economy that are or might be exploited by crime. This book is the outcome of a study known under the acronym MAVUS II (Method for and Assessment of Vulnerability of Sectors II) which addresses this issue. The study, financed under the 2005 AGIS programme of the European Commission, provides a vulnerability profile of the European pharmaceutical sector based on a new methodology to scan economic sectors for their vulnerability to (organised) crime. Both vulnerability study and methodological tool are intended as a guide for actions and initiatives to be taken by governments, law enforcement bodies and economic players.